18 February 2021
Visiongain has published a new report on Veterinary Anaesthesia Equipment Market Report 2021-2031: Forecasts by Animal Type, By End Use, By Product (Complete Anesthesia Machines, Ventilators, Accessories). PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Global Veterinary Anaesthesia Equipment market was valued at US$ xx billion in 2020 and is projected to reach at a market value of US$ xx billion by 2031.
The growing cases of oral diseases in dogs and cats are creating the need for veterinary machines for dental surgery, thereby providing opportunities to the manufactures dealing in the veterinary anesthesia equipment market.
Anesthesia is given to animals to deal with in-cooperative animals during diagnosis and therapeutic procedures. The key objective is to alleviate the surgical stress and pain management.
There are many ways of giving anesthesia to animals but most of the practitioners opt for anesthesia through air pressure using anesthesia machines. Anesthesia machines are safe, secure and are broadly used to handle the situation in a better way.The fast changing technology has resulted into evolution of anesthesia machines from un-connected to easy-to-carry wireless devices. Acceptance of the fast changing technology, manufacturers are introducing anesthesia machines with more advanced features.
Innovation of progressive features in anesthesia equipment, such as new ventilation mode, graphical screens, and clear picture offering loops, by manufacturers is expected to fuel the acceptance over the analysis period. Rising pet adoption inclination, pet-human bonding, and growingutilization of veterinary care products are also estimated to pave the way for the growth for the veterinary anesthesia machines market.
Moreover, rising occurrence of chronic diseases in acquaintance animals and escalating cases of accidental injuries in animals are also likely to fuel the growth of the market.
Modernexpansions in drug development processes in the field of veterinary medicine are enhancing the implementation of this equipment among veterinarians. Advancements in intravenous anesthesia, research relevant to efficient drug delivery to pets, and novel product sanctions are some of the primary growth aspects for the market. For instance, in July 2018 the Centre for Veterinary Medicine permitted anesthetic Alfaxan, which is intravenous injectable that offers an enlarged product shelf life.
Risingconcentration on animal healthcare is also working in favour of the market. Oral healthcarematters among cats and dogs have always remained a challenge for veterinarians. High demand for equipment and machines for dental surgeries of animals is anticipated to find a strong growth prospect for veterinary anesthesia equipment during the forecast period.
Global Veterinary Anaesthesia equipment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships,acquisitions and others to increase their footprints in this market.
Key players operating in the global veterinary anesthesia equipment market include DRE Veterinary, Mediquip Pty Ltd, Patterson Companies, Inc., VETLAND MEDICAL SALES & SERVICES, Smiths Medical, Kent Scientific Corporation, Henry Schein, Inc., Dispomed ltd, Midmark Corporation, and JD Medical.
Market participants are focusing on competitive tactics to upsurge their revenue share. Some of the growth strategies executed by them are a novel product launch, partnership and distribution agreements, and geographic expansions. For instance, in April 2017, Ivaoes Animal Health, LLC, operating as a subsidiary of Tri-Source Pharma, LLC, introduced an anesthetic product named Rapanofal, which is a Propofol Emulsion Injection approved for cats and dogs. Introduction of such new products in the market is anticipated to upkeep market growth.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Increasing investment in R&D for proteomics research, by both public and private organizations, is one of the major contributors to the growth of the protein labelling reagents market. The increasing prevalence of chronic diseases is also expected to contribute to the growth of this market.
05 May 2021
Over the last few years, the aptamers has gained widespread attention due to the technological advancements and growth in understanding of the oligonucleotide therapeutics that inhabit the human body.
29 April 2021
Rising prevalence of inflammatory bowel disease including Crohn’s disease and ulcerative colitis; raising awareness for IBD in developing countries; escalating investment in drug R&D by pharmaceutical companies; new product launches worldwide, growing chronic diseases healthcare awareness are some of the major factors that boosting the growth of global IBD drugs market.
29 April 2021
Rising incidences of viral infection; increasing geriatric population is projected to propel the demand for anti-viral drugs; advancement in anti-viral drugs R&D is driving the market growth; and rising strategic initiatives for anti-viral drugs market is another major factor propelling the market growth worldwide are some of the major factors that propel the global antiviral drugs treatment market growth.